新开普 reported revenue of ¥0.32B for the period ended 2026-06-30, +2.2% year on year. Net income was ¥-0.06B, a -20.0% net margin on a 50.1% gross margin. The largest revenue line is 智慧校园应用解决方案 at 43% of the total. Free cash flow for the period was ¥-0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.32B | +2.2% |
| Gross profit | ¥0.16B | — |
| Operating income | ¥-0.06B | — |
| Net income | ¥-0.06B | — |
| Gross margin | 50.1% | Net margin -20.0% |
| Revenue Q/Q | +54.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 智慧校园应用解决方案 | ¥0.14B | 43.5% |
| 智慧政企应用解决方案 | ¥0.10B | 30.9% |
| 运维服务 | ¥0.05B | 16.5% |
| 智慧校园云平台解决方案 | ¥0.03B | 9.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.16B | 49.9% |
| R&D | ¥0.07B | 23.1% |
| SG&A | ¥0.17B | 52.8% |
| Tax & other | ¥0.00B | 0.8% |
| Item | Amount |
|---|---|
| Total assets | ¥2.67B |
| Total liabilities | ¥0.41B |
| Shareholders' equity | ¥2.26B |
| Equity / assets | 84.5% |
| Operating cash flow | ¥-0.01B |
| Capital expenditure | ¥0.03B |
| Free cash flow | ¥-0.03B |
| Cash conversion (OCF / net income) | 155% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies